文献速递腹部CT

直方图与体积比定量CT评估吡咯里西啶生物碱致肝窦阻塞综合征

Quantitative CT assessment by histogram and volume ratio in pyrrolizidines alkaloids-induced hepatic sinusoidal obstruction syndrome.
PubMed 文献 · Eur J Radiol · 2021-03-06

回顾性纳入35例PAs诱导的HSOS患者,在门静脉期CECT上定量测量低强化体积比和直方图衍生的密度比变化(ΔDR)。损伤区平均HU显著低于正常肝实质;ΔDR与总胆红素、直接胆红素、碱性磷酸酶正相关,而低强化体积比无此相关性;联合评分的异质性低强化严重程度与凝血酶原时间、INR、碱性磷酸酶和MELD评分弱正相关。

要点

  • 门静脉期CECT上损伤区平均HU显著低于正常肝实质,提示低强化。
  • 异质性低强化按体积比和ΔDR评分:轻度13例、中度16例、重度6例。
  • ΔDR与总胆红素、直接胆红素、碱性磷酸酶正相关,低强化体积比无此相关性。

关键影像表现/征象

  • 损伤区平均HU为58.68 ± 17.3,显著低于对应正常肝实质的82.27 ± 23.97(P < 0.001)。
  • 异质性低强化程度:轻度13例(37%)、中度16例(46%)、重度6例(17%)。

诊断标准与关键数值

  • ΔDR与总胆红素(r = 0.341,P = 0.045)、直接胆红素(r = 0.385,P = 0.022)、碱性磷酸酶(r = 0.491,P = 0.003)呈弱至中度正相关。
  • 低强化体积比与上述临床因素未见相关性。
  • 体积比和ΔDR评分的异质性低强化严重程度与凝血酶原时间(r = 0.357,P = 0.035)、INR(r = 0.363,P = 0.032)、碱性磷酸酶(r = 0.359,P = 0.034)、MELD评分(r = 0.347,P = 0.041)呈弱正相关。

临床应用与阅片要点

  • 门静脉期CECT上可定量测量低强化体积比和ΔDR,辅助评估HSOS严重程度。
  • ΔDR与多项肝功能指标相关,低强化体积比无此相关性,阅片时可关注直方图衍生参数。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To quantitatively assess hypoattenuation volume ratio and hepatic parenchymal hypoattenuation on contrast enhanced computed tomography (CECT) in patients with pyrrolizidines alkaloids (PAs)-induced hepatic sinusoidal obstruction syndrome (HSOS), and evaluate the correlations of the CT-based quantitative values with clinical factors.

METHODS: Thirty-five patients with PAs-induced HSOS who underwent CECT were retrospectively enrolled. The ratio of hypoattenuation volume to total liver volume, and changes in damaged area-to-normal liver density ratio (ΔDR) derived from histogram on portal venous phase were quantitatively measured. Heterogeneous hypoattenuation (CT score) scored by hypoattenuation volume ratio and ΔDR were calculated. The correlation between imaging findings and clinical factors was analyzed using Pearson correlation test.

RESULTS: Liver function tests were abnormal in most patients, the mean Hounsfield unit (HU) of damaged area (58.68 ± 17.3) was significantly lower (P < 0.001) than the corresponding normal liver (82.27 ± 23.97). Heterogeneous hypoattenuation were mild in 13 patients (37 %), moderate in 16 patients (46 %), and severe in 6 patients (17 %). ΔDR derived from histogram was positively correlated (weakly to moderately) with total bilirubin (r = 0.341, P = 0.045), direct bilirubin (r = 0.385, P = 0.022), and alkaline phosphatase (r = 0.491, P = 0.003), while such correlation was not observed in hypoattenuation volume ratio. The severity of heterogeneous hypoattenuation scored by hypoattenuation volume ratio and ΔDR was positively correlated (weakly) with prothrombin time (r = 0.357, P = 0.035), international normalized ratio (r = 0.363, P = 0.032), alkaline phosphatase (r = 0.359, P = 0.034), and model for end-stage liver disease (MELD) score (r = 0.347, P = 0.041).

CONCLUSION: Heterogeneous hypoattenuation scored by volume ratio and ΔDR on CECT provides a non-invasive approach in evaluating the severity of PAs-induced HSOS.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Yang X, Lei P, Song Y, et al. Quantitative CT assessment by histogram and volume ratio in pyrrolizidines alkaloids-induced hepatic sinusoidal obstruction syndrome. Eur J Radiol. 2021. PMID: 33711570. doi:10.1016/j.ejrad.2021.109632

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。